Pharma Journalist - Page 8 of 847 -

Sangamo and Lilly Partner on Capsid License for CNS Genomic Medicines

Boehringer Ingelheim Expands ADC Portfolio with New R&D Center in Basel

Neurona Therapeutics Raises $102M for NRTX-1001 Phase 3 Trial

EMA Validates Gilead’s Application for Twice-Yearly Lenacapavir as HIV Prevention

Teva and Alvotech Launch SELARSDI Injection in the U.S.

Boehringer’s Zongertinib Gets U.S. FDA Priority Review for HER2-Mutant Advanced NSCLC

FDA Grants ImmunityBio Approval to Supply Recombinant BCG (rBCG) Amid TICE BCG Shortage

Rznomics Inc. Liver Cancer Drug Receives Fast Track Designation

FDA Accepts Dupixent sBLA for Bullous Pemphigoid Treatment under Priority Review

FDA Accepts Gilead’s NDA for Twice-Yearly Lenacapavir for HIV Prevention

Biogen and Stoke Therapeutics Partner to Develop Zorevunersen for Dravet Syndrome Treatment

FDA Grants Breakthrough Therapy Designation to Innate Pharma’s Lacutamab for Sézary Syndrome

FDA Grants Full Approval of Deciphera’s ROMVIMZA for TGCT Treatment